Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction

Heart Failure Reviews

Volumn 6, Issue 3, 2001, Pages 163-175

  Mitropoulos, Md, Fotios A ^a   Elefteriades Md, John A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced ventricular dysfunction; Congestive heart failure; Coronary artery bypass grafting; Ischemic cardiomyopathy; Low ejection fraction

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGINA PECTORIS; CARDIOMEGALY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG TERM CARE; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PATIENT REFERRAL; PATIENT SELECTION; PERIOPERATIVE PERIOD; PROGNOSIS; PULMONARY HYPERTENSION; QUALITY OF LIFE; REOPERATION; REVIEW; SAFETY; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME;

AGED; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; MALE; PATIENT SELECTION; PERIOPERATIVE CARE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION;

EID: 0034917731     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011416929501     Document Type: Review

References (57)

1. Trends in hospitalization rates for heart failure in the United States, 1973-1986: Evidence for increasing population prevalence
2. Chronic heart failure in the United States. A manifestation of coronary artery disease
3. National hospital discharges survey: Annual summary 1993
4. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy
5. Management of heart failure III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction
6. Evidence based contemporary heart failure management
7. Cost effective management of heart failure
8. Coronary Artery Surgery Study (CASS): A randomized trial of coronary artery bypass surgery. Survival data
9. Long term results of prospective randomized trial of coronary artery bypass surgery in stable angina pectoris
10. When does one replace the heart in ischemic cardiomyopathy?
11. Donor availability as the primary determinant of the future of heart transplantation
12. The registry of the international society for heart and lung transplantation: Ninth official report - 1992
13. Importance of diagnosing hibernating myocardium: How and in whom?
14. The hibernating myocardium in ischemia and congestive heart failure
15. Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < or = 30%
16. Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state
17. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome
18. Oral presentation "revascularization outcomes"
19. Efficacy and cost-effectiveness of preoperative IABP in patients with ejection fraction of 0.25 or less
20. Coronary bypass: The bad ventricle
21. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction
22. Results of revascularization in patients with severe left ventricular dysfunction
23. The importance of completeness of revascularization during long-term follow-up after coronary artery operations
24. Does the extended use of arterial grafts compromise the myocardial recovery after coronary artery bypass grafting in left ventricular dysfunction
25. Primary coronary artery bypass grafting without cardiopulmonary bypass in impaired left ventricular function
26. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators
27. CABG in advanced left ventricular dysfunction
28. Myocardial viability assessment in ischemic cardiomyopathy: Benefits of coronary revascularization
29. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation
30. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions
31. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201TI single-photon emission computed tomography
32. Prediction of outcome after revascularization in patients with poor left ventricular function
33. Prospective evaluation of viable myocardium by quantitative dipyridamole-thalium-201 scintigraphy and radionuclide ventriculography
34. Recovery of myocardial function
35. Predicting outcome after myocardial revascularization in patients with left ventricular dysfunction
36. Increased risk of coronary artery bypass grafting for left ventricular dysfunction with dilated left ventricle
37. Is reoperative coronary artery bypass grafting in patients with poor left ventricular ejection fractions < or = 25% worthwhile?
38. Intermediate-term outcome of mitral reconstruction in cardiomyopathy
39. Coronary artery bypass grafting in patients with poor ventricular function
40. Improved long-term survival following myocardial revascularization in patients with severe left ventricular dysfunction
41. Coronary artery bypass grafting in patients with profound ventricular dysfunction
42. Myocardial revascularization for severe left ventricular dysfunction. Factors influencing early and late survival
43. Decision-making in endstage coronary artery disease: Revascularization or heart transplantation?
44. Long-term results of coronary artery bypass surgery in patients with severely depressed left ventricular function
45. Coronary artery bypass in patients with severely depressed ventricular function
46. Coronary artery bypass grafting in patients with ejection fractions below forty percent. Early and late results in 466 patients
47. Results of coronary artery surgery in patients with poor left ventricular function (CASS)
48. Surgical survival benefits for coronary disease patients with left ventricular dysfunction
49. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support
50. Predicting survival after coronary revascularization for ischemic cardiomyopathy
51. The risks of reoperative coronary artery bypass in chronic ischemic cardiomyopathy: Results of the CABG patch trial
52. Severe ischemic left ventricular failure: Coronary operation or heart transplantation
53. High-risk cardiac operation: A viable alternative to heart transplantation
54. Analysis of morbid events and risk factors for death after cardiac transplantation
55. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less
56. Effect of low ventricular ejection fractions on the outcome of primary coronary bypass grafting in end-stage coronary artery disease